Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Neurology

  • 1
    News

    Lower target LDL-C cuts risk of CV events in ischemic stroke patients

    April 23, 2021

    Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?

  • News

    Stroke is ‘not a common complication’ in COVID-19

    April 20, 2021

    Among the sickest of COVID patients – those admitted to an ICU – researchers found that stroke was not a common complication.

  • News

    Watch for abnormal movements in hospitalized COVID-19 patients

    April 19, 2021

    “A heightened awareness of abnormal eye movements, or subtle facial tremoring, may be the first steps in recognizing potentially dangerous neurologic manifestations,” the researchers said.

  • News

    How some COVID-19 vaccines could cause rare blood clots

    April 14, 2021

    Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.

  • News

    Novel antiplatelet drug: Hope for efficacy without bleeding?

    April 12, 2021

    A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.

  • News

    AstraZeneca COVID vaccine: Clotting disorder mechanism revealed?

    April 2, 2021

    The vaccine may be linked to a condition that clinically resembles heparin-induced thrombocytopenia and seems to occur mainly in younger women.

  • 1
    News

    Encephalopathy common, often lethal in hospitalized patients with COVID-19

    March 29, 2021

    Toxic metabolic encephalopathy was associated with a 24% higher risk of in-hospital death.

  • News

    Late-window stroke thrombolysis not linked to clot migration

    March 3, 2021

    This is the first randomized controlled study to assess the effect of thrombolysis on clot migration and accessibility in an extended time window.

  • 1
    News

    Neurologic disorders ubiquitous and rising in the U.S.

    March 2, 2021

    Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level or declining, offering hope that prevention measures may be having an effect.

  • 1
    News

    Loss of smell lingers post COVID-19

    February 24, 2021

    The fact that the sense of smell had not returned to normal for half the participants so long after being infected is “novel and quite striking.”

Previous1 … 4 5 6 7 8 … 38Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences